GT Biopharma, Inc. ( GTBP) - Stock Earnings
GTBP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
GTBP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 8.3 million USD | — USD |
| 2025Q4 | -23.0 million USD | — USD |
| 2026Q1 | -2.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GTBP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.6 million USD | — USD |
| 2024 | -13.2 million USD | — USD |
| 2025 | -28.4 million USD | — USD |
| 2026 Est. | — | — |
GTBP
Price: $0.32
52 week price:
Earnings Per Share: -6.46 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 64789
Market Capitalization: 5.0 million